This week’s news and article recap

For the latest news from Pituitary World News.Subscribe free here Recordati RD announced that a new indication for Osilodrostat for endogenous Cushing’s syndrome will be presented for FDA approval this fall. Read the company’s press

2023 Pituitary Conference

We’re delighted to announce the 2023 Pituitary Conference on Saturday, December 9, 2023, from 8:00 a.m. to 4:00 p.m. at the UCSF Mission Bay Genentech Hall, 600 16th Street, San Francisco, CA. Join us for

Life isn’t healed after surgery

A young woman called me last year to make an appointment. She told me she had recently had endoscopic neurosurgery for craniopharyngioma. She was suffering from severe anxiety and depression. She hoped to find a mental health professional who would understand the critical link between the endocrine system and her mental health symptoms.